NASDAQ:RKDA Arcadia Biosciences Q3 2026 Earnings Date & Estimates $0.21 -0.02 (-8.19%) As of 04:00 PM Eastern Arcadia Biosciences is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeBefore Market Opens Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Arcadia Biosciences in Q3 2026Arcadia Biosciences is expected to post earnings of -$0.46 per share on revenue of $2.40 million. In the same quarter a year earlier Arcadia Biosciences reported $0.62 per share on revenue of $1.30 million. Arcadia Biosciences last reported on August 13, 2026, posting -$2.09 per share and missing the -$0.56 consensus estimate. Arcadia Biosciences has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.46Expected Revenue$2.40 millionPrior-Year EPS$0.62Prior-Year Revenue$1.30 millionExpected EPS Growth-174.2%Expected Revenue Growth+84.3%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$2.09 (Missed by -$1.53)Last Quarter Revenue$1.44 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Arcadia Biosciences Q3 2026 Earnings FAQ When does Arcadia Biosciences report Q3 2026 earnings? Arcadia Biosciences (NASDAQ:RKDA) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Arcadia Biosciences' Q3 2026 earnings call? Arcadia Biosciences' Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Arcadia Biosciences? Analysts expect Arcadia Biosciences to post earnings of -$0.46 per share for Q3 2026. How much revenue is Arcadia Biosciences expected to report? The consensus revenue estimate for Arcadia Biosciences is $2.40 million for Q3 2026. Arcadia Biosciences Earnings HeadlinesArcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Large Increase in Short InterestOctober 10 at 2:23 AM | americanbankingnews.comArcadia Biosciences (NASDAQ:RKDA) Shares Cross Below 50-Day Moving Average - Here's What HappenedOctober 7, 2026 | americanbankingnews.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 13 at 1:00 AM | Stansberry Research (Ad)Financial Contrast: Arcadia Biosciences (NASDAQ:RKDA) & Constellation Brands (NYSE:STZ)October 4, 2026 | americanbankingnews.comArcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business HighlightsAugust 13, 2026 | globenewswire.comRKDA Share News TodayJuly 6, 2026 | uk.investing.comSee More Arcadia Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email. Email Address About Arcadia BiosciencesArcadia Biosciences (NASDAQ:RKDA) is an agricultural biotechnology company focused on developing and commercializing plant-based products and crop technologies designed to address health, nutrition and sustainability needs. The company has worked to improve the nutritional profile and agricultural performance of crops through biotechnology and plant-breeding programs. Arcadia’s product portfolio has included GoodWheat, a line of wheat varieties and wheat-based foods developed to contain reduced levels of gluten and other targeted nutritional characteristics. The company has also pursued hemp-related products and other consumer health and wellness offerings, while historically developing crop traits intended to improve characteristics such as nitrogen-use efficiency, salinity tolerance and yield. Founded in 2002, Arcadia Biosciences has been based in Davis, California, and has served agricultural, food and consumer markets through research, product development, licensing and commercialization activities. Its business focus and product portfolio have evolved over time as the company has emphasized commercial opportunities in plant-based nutrition and wellness.View Arcadia Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry5 Retail Picks to Watch as the Holiday Shopping Season Nears Upcoming Earnings Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026)Fastenal (10/14/2026)ASML (10/14/2026)Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
